Stone Point Wealth LLC Pfizer Inc Transaction History

Stone Point Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $2,888 - $3,375	-90 Reduced 1.2%	7,437 $246,000
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $17,048 - $19,724	-472 Reduced 5.9%	7,527 $276,000
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $2,481 - $3,230	-63 Reduced 0.78%	7,999 $326,000
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $1,137 - $1,388	-26 Reduced 0.32%	8,062 $353,000
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $370,026 - $458,508	8,088 New	8,088 $417,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Stone Point Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Point Wealth LLC with notifications on news.